Evidence map›Paper›PMID 30213627›Full record

ArticleThe Journal of allergy and clinical immunology2019

Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes.

Alkis Togias, Peter J Gergen, Jack W Hu, Denise C Babineau, Robert A Wood, Robyn T Cohen, Melanie M Makhija, Gurjit K Khurana Hershey, Carolyn M Kercsmar, Rebecca S Gruchalla and 9 more

Abstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Evolution of IgE sensitization profiles toThe World Allergy Organization journal · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Comparative analysis of masseter muscle electrical activity by nasal patency in children with rhinitis and asthma: a pilot observational study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Observational
  11. IL-1β and iNOS can drive the asthmatic comorbidities and decrease of lung function in perennial allergic rhinitis children.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Article
  12. Review
  13. [The need for an integrated approach to rhinitis and asthma]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2023
    Article
  14. Racial and Ethnic Disparities in Allergen Immunotherapy Prescription for Allergic Rhinitis.The journal of allergy and clinical immunology. In practice · 2023
    Article
  15. Allergic rhinitis co-morbidity on asthma outcomes in city school children.The Journal of asthma : official journal of the Association for the Care of Asthma · 2023
    Article
  16. Treatment with pollen allergen immunotherapy improves health-related quality of life in children and adolescents: a three-year follow-up-study.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. The Role of Comorbidities in Difficult-to-Control Asthma in Adults and Children.The journal of allergy and clinical immunology. In practice · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 1 country.

Alkis TogiasDivision of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Peter J GergenDivision of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Jack W HuRho Federal Systems Division, Chapel Hill, MC. Electronic address: jack_hu@rhoworld.com.
Denise C BabineauRho Federal Systems Division, Chapel Hill, MC.
Robert A WoodDivision of Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Robyn T CohenDepartment of Pediatrics, Boston University School of Medicine, Boston, Mass.
Melanie M MakhijaDivision of Allergy and Immunology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.
Gurjit K Khurana HersheyDivision of Asthma Research and Division of Pulmonary Medicine, Cincinnati Children's Hospital, Cincinnati, Ohio.
Carolyn M KercsmarDivision of Asthma Research and Division of Pulmonary Medicine, Cincinnati Children's Hospital, Cincinnati, Ohio.
Rebecca S GruchallaUniversity of Texas Southwestern Medical Center, Dallas, Tex.
Andrew H LiuDivision of Allergy and Immunology, National Jewish Health, Denver, and the Department of Allergy and Immunology, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colo.
Emily WangDivision of Allergy and Immunology, Henry Ford Health System, Detroit, Mich.
Haejin KimDivision of Allergy and Immunology, Henry Ford Health System, Detroit, Mich.
Carin I LammDepartment of Pediatrics, College of Physicians and Surgeons, New York, NY.
Leonard B BacharierDivision of Allergy, Immunology, and Pulmonary Medicine, St Louis Children's Hospital, St Louis, Mo.
Dinesh PillaiDepartment of Pulmonary Medicine, Children's National Health System, Washington, DC.
Steve M SigelmanDivision of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
James E GernDivision of Allergy and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
William W BusseDivision of Allergy and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
National Institute of Allergy and Infectious Diseases · USCincinnati Children's Hospital Medical Center · USHenry Ford Health System · USUniversity of Wisconsin–Madison · USBoston University · USChildren's National · USJohns Hopkins University · USLurie Children's Hospital · USNational Jewish Health · USSt. Louis Children's Hospital · USThe University of Texas Southwestern Medical Center · US

Funding

Transplantation GroupUM2AI117870 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI DAVID, GLORIA · 2015 to 2023
$208.1M
Inner City Asthma consortium 3 (ICAC3)UM1AI114271 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E., JACKSON, DANIEL J · 2014 to 2021
$79.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI MEINZEN-DERR, JAREEN, STRAWN, JEFFREY ROBERT · 2015 to 2024
$37.5M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR000075NCATS NIH HHS UL1 TR000077NCATS NIH HHS UL1 TR000150NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR000451NCATS NIH HHS UL1 TR001079NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR001105NCATS NIH HHS UL1 TR001422NCATS NIH HHS UL1 TR001425NCATS NIH HHS UL1 TR002535NCATS NIH HHS UL1 TR003098NCRR NIH HHS UL1 RR025780NIAID NIH HHS HHSN272200900052CNIAID NIH HHS HHSN272201000052INIAID NIH HHS UM1 AI114271NIAID NIH HHS UM2 AI117870
6 · The paper itself

Abstract

backgroundRhinitis and asthma are linked, but substantial knowledge gaps in this relationship exist.

objectiveWe sought to determine the prevalence of rhinitis and its phenotypes in children and adolescents with asthma, assess symptom severity and medication requirements for rhinitis control, and investigate associations between rhinitis and asthma.

methodsSeven hundred forty-nine children with asthma participating in the Asthma Phenotypes in the Inner-City study received baseline evaluations and were managed for 1 year with algorithm-based treatments for rhinitis and asthma. Rhinitis was diagnosed by using a questionnaire focusing on individual symptoms, and predefined phenotypes were determined by combining symptom patterns with skin tests and measurement of serum specific IgE levels.

resultsAnalyses were done on 619 children with asthma who completed at least 4 of 6 visits. Rhinitis was present in 93.5%, and phenotypes identified at baseline were confirmed during the observation/management year. Perennial allergic rhinitis with seasonal exacerbations was most common (34.2%) and severe. Nonallergic rhinitis was least common (11.3%) and least severe. The majority of children remained symptomatic despite use of nasal corticosteroids with or without oral antihistamines. Rhinitis was worse in patients with difficult-to-control versus easy-to-control asthma, and its seasonal patterns partially corresponded to those of difficult-to-control asthma.

conclusionRhinitis is almost ubiquitous in urban children with asthma, and its activity tracks that of lower airway disease. Perennial allergic rhinitis with seasonal exacerbations is the most severe phenotype and most likely to be associated with difficult-to-control asthma. This study offers strong support to the concept that rhinitis and asthma represent the manifestations of 1 disease in 2 parts of the airways.

Indexed as

AdolescentAdrenergic beta-2 Receptor AgonistsAnti-Allergic AgentsAsthmaBronchodilator AgentsChildFemaleFluticasoneHumansMalePhenotypePrevalenceRhinitisSalmeterol XinafoateSeverity of Illness IndexAdrenergic beta-2 Receptor AgonistsAnti-Allergic AgentsBronchodilator AgentsFluticasoneSalmeterol Xinafoateasthmarhinitis managementrhinitis phenotypesRhinitis prevalencerhinoconjunctivitis

Identifiers

PMID30213627
PMCPMC6408960
OpenAlexW2891318481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.